DANIEL VAN DEN BERGH
Partner at Kaiser Permanente Ventures
About
Daniel van den Bergh is a Partner at Kaiser Permanente Ventures, where he plays a pivotal role in identifying and supporting innovative companies transforming healthcare. His investment focus spans digital health, medical devices, and tech-enabled services that align with Kaiser Permanente's mission to enhance patient care and outcomes.
Recent News & Mentions
Experience
Deep Dive
As a distinguished Partner at Kaiser Permanente Ventures, Daniel van den Bergh is at the forefront of identifying and nurturing groundbreaking companies poised to reshape the healthcare landscape. Kaiser Permanente Ventures, the corporate venture arm of one of America's leading healthcare providers, strategically invests in innovative solutions that enhance care delivery, improve patient experiences, and drive operational efficiencies.
In his capacity as Partner, Daniel is deeply involved in all facets of the investment process. This includes sourcing promising startups, conducting rigorous due diligence, structuring investment deals, and actively supporting portfolio companies post-investment. His work is critical in ensuring that Kaiser Permanente Ventures' investments not only generate financial returns but also align with Kaiser Permanente's broader strategic goals of advancing health and wellness for its members and communities. He collaborates closely with clinical and operational leaders within Kaiser Permanente to identify areas ripe for innovation and to integrate successful solutions into the healthcare system.
Daniel's investment focus areas are broad yet strategic, reflecting the evolving needs of modern healthcare. He is particularly interested in digital health platforms, health information technology, medical devices, diagnostics, and tech-enabled services that offer scalable solutions to complex healthcare challenges. This includes innovations in telehealth, remote patient monitoring, artificial intelligence in healthcare, data analytics, and personalized medicine. His expertise helps Kaiser Permanente Ventures pinpoint technologies and business models that can truly make a difference in patient outcomes and healthcare accessibility.
While specific notable investments attributed solely to Daniel are often part of a broader team effort at Kaiser Permanente Ventures, his contributions are instrumental in building a robust portfolio of companies that are making significant strides in their respective fields. The firm's portfolio includes leaders in various health tech sectors, and Daniel's insights help guide these companies toward successful growth and integration within the healthcare ecosystem.
Prior to his role at Kaiser Permanente Ventures, Daniel van den Bergh cultivated a strong background in healthcare investment and finance. This experience has equipped him with a deep understanding of market dynamics, regulatory environments, and the unique challenges and opportunities within the healthcare industry. His career trajectory demonstrates a consistent commitment to leveraging capital and strategic partnerships to foster innovation that ultimately benefits patients and providers alike. Daniel's leadership continues to drive Kaiser Permanente Ventures' mission to invest in the future of healthcare.
Frequently Asked Questions
Who is Daniel van den Bergh?
Daniel van den Bergh is a Partner at Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente. He is responsible for identifying, evaluating, and investing in innovative healthcare companies.
What does Daniel van den Bergh invest in?
Daniel van den Bergh primarily invests in companies within the healthcare sector that align with Kaiser Permanente's strategic priorities. His focus areas include digital health, health information technology, medical devices, diagnostics, and tech-enabled services aimed at improving patient care and operational efficiency.
Where does Daniel van den Bergh work?
Daniel van den Bergh works as a Partner at Kaiser Permanente Ventures. This organization is based in the United States and is dedicated to investing in companies that innovate and transform the healthcare industry.